Brain Stimulation Devices: Understanding Deep Brain Stimulation: Applications and Mechanisms

1. What are brain stimulation devices and how do they work?

brain stimulation devices are medical devices that use electrical currents or magnetic fields to modulate the activity of specific brain regions. They can be used to treat various neurological and psychiatric disorders, such as Parkinson's disease, epilepsy, depression, and chronic pain. Brain stimulation devices can be classified into two main types: invasive and non-invasive.

- Invasive brain stimulation devices are implanted surgically into the brain or the skull. They deliver electrical stimulation directly to the target brain area through electrodes. The most common example of invasive brain stimulation is deep brain stimulation (DBS), which involves implanting a pulse generator in the chest and connecting it to electrodes in the brain. DBS can be used to treat movement disorders, such as Parkinson's disease, essential tremor, and dystonia, by stimulating the subthalamic nucleus, the globus pallidus, or the thalamus. DBS can also be used to treat other conditions, such as obsessive-compulsive disorder, Tourette syndrome, and depression, by stimulating the nucleus accumbens, the ventral capsule/ventral striatum, or the subgenual cingulate cortex.

- Non-invasive brain stimulation devices are applied externally to the scalp or the head. They deliver electrical or magnetic stimulation through the skin and the skull to the underlying brain tissue. The most common examples of non-invasive brain stimulation are transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). TMS uses a coil to generate a magnetic field that induces an electric current in the brain. TMS can be used to treat depression, migraine, stroke, and schizophrenia, by stimulating the dorsolateral prefrontal cortex, the motor cortex, or the cerebellum. TDCS uses a battery-powered device to deliver a low-intensity direct current to the brain. TDCS can be used to enhance cognitive functions, such as memory, attention, and learning, by stimulating the prefrontal cortex, the parietal cortex, or the temporal cortex.

Brain stimulation devices work by altering the excitability and the connectivity of the neurons in the target brain region. Depending on the parameters of the stimulation, such as the intensity, the frequency, the duration, and the polarity, brain stimulation devices can either increase or decrease the firing rate of the neurons, or change the synaptic strength between the neurons. By doing so, brain stimulation devices can modulate the neural circuits that are involved in various cognitive, emotional, and behavioral processes. For example, DBS can reduce the symptoms of Parkinson's disease by restoring the balance between the direct and the indirect pathways of the basal ganglia, which are responsible for initiating and inhibiting movements. TMS can improve the mood of depressed patients by increasing the activity of the left prefrontal cortex, which is associated with positive emotions and motivation. TDCS can enhance the memory performance of healthy subjects by facilitating the long-term potentiation of the hippocampus, which is involved in encoding and retrieving information.

2. History and development of deep brain stimulation (DBS)

Deep brain stimulation (DBS) is a form of neuromodulation that involves delivering electrical impulses to specific brain regions through implanted electrodes. DBS has been used to treat various neurological and psychiatric disorders, such as Parkinson's disease, essential tremor, dystonia, epilepsy, obsessive-compulsive disorder, and depression. The history and development of DBS can be traced back to several milestones and discoveries in the fields of neurology, neurosurgery, and neurophysiology. Some of these are:

1. The first experimental evidence of electrical stimulation of the brain was obtained by Gustav Fritsch and Eduard Hitzig in 1870, who showed that applying a weak current to the exposed cortex of a dog could elicit movements of the opposite side of the body.

2. The first human application of electrical stimulation of the brain was performed by Robert Bartholow in 1874, who stimulated the exposed cortex of a patient with a scalp tumor and observed contralateral movements and sensations.

3. The first surgical lesioning of the brain for therapeutic purposes was done by Victor Horsley and Robert Clarke in 1886, who removed a portion of the motor cortex of a patient with epilepsy and reduced the frequency of seizures.

4. The first stereotactic device for precise targeting of brain structures was invented by Ernst Spiegel and Henry Wycis in 1947, who used it to perform thalamotomies (destruction of the thalamus) for patients with Parkinson's disease and other movement disorders.

5. The first chronic implantation of electrodes in the brain for stimulation was performed by Irving Cooper in 1953, who implanted wires in the globus pallidus of a patient with dystonia and achieved improvement of symptoms.

6. The first use of radiofrequency to control the stimulation parameters of implanted electrodes was demonstrated by William Sweet and Robert Mark in 1960, who stimulated the thalamus of a patient with chronic pain and observed relief of pain.

7. The first clinical trial of DBS for Parkinson's disease was conducted by Alim Benabid and Pierre Pollak in 1987, who stimulated the subthalamic nucleus of a patient with advanced Parkinson's disease and observed dramatic improvement of motor function.

8. The first FDA approval of DBS for a neurological disorder was granted in 1997, for the treatment of essential tremor by stimulating the ventral intermediate nucleus of the thalamus.

9. The first FDA approval of DBS for a psychiatric disorder was granted in 2009, for the treatment of obsessive-compulsive disorder by stimulating the anterior limb of the internal capsule.

DBS has evolved over the years from a crude and invasive technique to a sophisticated and minimally invasive therapy, thanks to the advances in neuroimaging, neuroengineering, and neurostimulation. The mechanisms of action of DBS are still not fully understood, but some hypotheses include modulation of neuronal activity, synaptic plasticity, neurotransmitter release, and network connectivity. DBS has shown promising results for many conditions, but it also has limitations and risks, such as infection, hemorrhage, hardware malfunction, and side effects. Therefore, DBS should be considered as a last resort option for patients who have failed to respond to other treatments and who are willing to undergo a complex and lifelong procedure.

3. Benefits and risks of DBS for various neurological and psychiatric disorders

Deep brain stimulation (DBS) is a surgical procedure that involves implanting electrodes in specific areas of the brain and connecting them to a battery-powered device called a neurostimulator. The neurostimulator delivers electrical impulses to the brain, which can modulate the activity of neural circuits involved in various neurological and psychiatric disorders. DBS has been approved by the FDA for the treatment of Parkinson's disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy. It is also being investigated for other conditions such as depression, Tourette syndrome, Alzheimer's disease, chronic pain, and addiction.

DBS has shown promising results in improving the symptoms and quality of life of many patients who do not respond well to medications or other therapies. However, DBS is not a cure and it does not stop the progression of the underlying disease. It also carries some risks and limitations that need to be carefully weighed against the potential benefits. Some of the benefits and risks of DBS for various disorders are:

- Parkinson's disease: DBS can reduce the motor symptoms of Parkinson's disease, such as tremor, rigidity, bradykinesia, and dyskinesia. It can also improve the response to levodopa, reduce the fluctuations and side effects of medication, and enhance the daily functioning and mood of patients. However, DBS does not improve the non-motor symptoms of Parkinson's disease, such as cognitive impairment, dementia, depression, anxiety, psychosis, and autonomic dysfunction. It may also cause some adverse effects, such as infection, bleeding, stroke, headache, speech problems, balance problems, and personality changes.

- Essential tremor: DBS can effectively reduce the tremor in the hands, arms, head, and voice of patients with essential tremor. It can also improve the ability to perform daily activities, such as writing, eating, drinking, and dressing. However, DBS does not eliminate the tremor completely and it may recur or worsen over time. It may also cause some complications, such as infection, bleeding, stroke, headache, speech problems, balance problems, and paresthesia (tingling or numbness).

- Dystonia: DBS can decrease the involuntary muscle contractions and spasms that cause abnormal postures and movements in patients with dystonia. It can also improve the pain, disability, and quality of life of patients. However, DBS does not cure dystonia and it may not work for all types of dystonia. It may also cause some side effects, such as infection, bleeding, stroke, headache, speech problems, balance problems, and paresthesia.

- Obsessive-compulsive disorder: DBS can reduce the severity and frequency of obsessive thoughts and compulsive behaviors in patients with obsessive-compulsive disorder (OCD) who do not respond to medications or psychotherapy. It can also improve the mood, anxiety, and functioning of patients. However, DBS does not eliminate OCD completely and it may require additional psychological interventions. It may also cause some adverse events, such as infection, bleeding, stroke, headache, speech problems, balance problems, and mood changes.

- Epilepsy: DBS can reduce the number and intensity of seizures in patients with epilepsy who do not respond to medications or surgery. It can also improve the quality of life and cognitive function of patients. However, DBS does not stop the seizures completely and it may not work for all types of epilepsy. It may also cause some complications, such as infection, bleeding, stroke, headache, speech problems, balance problems, and paresthesia.

4. How does it modulate neural activity and plasticity?

One of the most intriguing questions in the field of brain stimulation devices is how deep brain stimulation (DBS) affects the neural activity and plasticity of the targeted brain regions and networks. DBS is a surgical procedure that involves implanting electrodes in specific areas of the brain and delivering electrical pulses through a battery-powered device called a neurostimulator. DBS has been shown to be effective in treating various neurological and psychiatric disorders, such as Parkinson's disease, essential tremor, dystonia, epilepsy, obsessive-compulsive disorder, and depression. However, the exact mechanisms of action of DBS remain unclear and are the subject of intense research.

Several hypotheses have been proposed to explain how DBS modulates neural activity and plasticity, which can be broadly classified into two categories: direct and indirect effects. Direct effects refer to the changes in the firing patterns and synaptic transmission of the neurons within the stimulation site, while indirect effects refer to the changes in the connectivity and function of the brain regions and networks that are connected to the stimulation site. These effects may vary depending on the stimulation parameters, such as frequency, intensity, pulse width, and duration, as well as the anatomical and functional characteristics of the target and its associated circuits. Some of the main hypotheses are:

- Depolarization blockade: This hypothesis suggests that high-frequency DBS (above 100 Hz) causes a sustained depolarization of the neuronal membrane, which prevents the generation of action potentials and effectively silences the neurons within the stimulation site. This may result in a functional lesion of the target area, which may normalize the abnormal activity of the downstream regions and networks. For example, DBS of the subthalamic nucleus (STN) in Parkinson's disease may reduce the excessive output of the STN to the globus pallidus and the thalamus, which may restore the balance of the basal ganglia circuit and improve the motor symptoms. However, this hypothesis does not account for the low-frequency DBS (below 50 Hz) that has been shown to be effective in some disorders, such as depression and epilepsy, nor for the fact that DBS may also activate axons and fibers of passage that originate or terminate outside the stimulation site.

- Synaptic plasticity: This hypothesis suggests that DBS induces changes in the strength and efficacy of the synaptic connections between the neurons within and around the stimulation site, which may alter the neural network dynamics and function. These changes may involve both long-term potentiation (LTP) and long-term depression (LTD), which are forms of synaptic plasticity that increase or decrease the synaptic response, respectively, in response to repeated or prolonged stimulation. DBS may induce synaptic plasticity by modulating the release of neurotransmitters, such as glutamate and dopamine, and the activation of receptors, such as NMDA and AMPA, which are involved in the induction and maintenance of LTP and LTD. For example, DBS of the nucleus accumbens (NAc) in depression may increase the release of dopamine and the expression of AMPA receptors in the NAc and the prefrontal cortex, which may enhance the reward and motivation circuits and improve the mood symptoms.

- Network modulation: This hypothesis suggests that DBS influences the activity and connectivity of the large-scale brain networks that are involved in the pathophysiology of the disorders. DBS may affect the network properties, such as synchronization, coherence, phase, and amplitude, of the neural oscillations that reflect the communication and integration of the brain regions. DBS may also affect the functional connectivity, which measures the statistical dependence and correlation of the neural signals, and the effective connectivity, which measures the causal influence and directionality of the neural signals, between the brain regions. For example, DBS of the anterior thalamic nucleus (ATN) in epilepsy may reduce the synchronization and coherence of the theta and gamma oscillations in the ATN and the hippocampus, which may disrupt the seizure propagation and generation. DBS may also increase the functional and effective connectivity between the ATN and the frontal cortex, which may enhance the cognitive and memory functions.

5. Technical, ethical, and social issues

Despite the promising results of DBS in treating various neurological and psychiatric disorders, there are still many challenges and limitations that need to be addressed before it can be widely adopted as a safe and effective therapy. Some of these issues are related to the technical aspects of DBS, such as the optimal selection of stimulation parameters, the durability and compatibility of the implanted devices, and the potential side effects and complications of the surgery. Other issues are more ethical and social in nature, such as the impact of DBS on the patients' personality, autonomy, and identity, the informed consent and decision-making process, and the social stigma and discrimination that may arise from using a brain implant. In this section, we will discuss some of these issues in more detail and explore the possible solutions and implications for the future of DBS.

- Technical issues: One of the main technical challenges of DBS is to find the optimal stimulation parameters for each patient, such as the frequency, intensity, pulse width, and duration of the electrical impulses. These parameters may vary depending on the target brain region, the type and severity of the disorder, and the individual response of the patient. Moreover, these parameters may need to be adjusted over time as the patient's condition changes or as the device wears out. Currently, there is no standardized or objective method to determine the best stimulation settings for each patient, and the process often involves trial and error and subjective feedback from the patient and the clinician. This may lead to suboptimal outcomes, adverse effects, or unnecessary battery consumption. To overcome this challenge, some researchers have proposed to use closed-loop or adaptive DBS systems, which can monitor the brain activity or the behavioral state of the patient and adjust the stimulation parameters accordingly in real time. For example, a closed-loop DBS system for Parkinson's disease could detect the onset of tremors or dyskinesia and modulate the stimulation to suppress them, while a closed-loop DBS system for depression could sense the mood or emotional state of the patient and deliver the appropriate stimulation to enhance it. However, closed-loop DBS systems also pose some technical difficulties, such as the need for reliable and robust sensors, the development of accurate and efficient algorithms, and the integration of multiple signals and modalities.

- Another technical issue of DBS is the durability and compatibility of the implanted devices. The DBS system consists of three main components: the electrodes that are inserted into the brain, the extension wires that connect the electrodes to the pulse generator, and the pulse generator that is implanted under the skin of the chest or abdomen. These components are subject to mechanical stress, corrosion, infection, inflammation, or rejection by the body, which may compromise their function or cause damage to the surrounding tissues. For instance, the electrodes may migrate, fracture, or erode over time, leading to loss of efficacy, stimulation of unwanted areas, or hemorrhage. The extension wires may break, twist, or dislodge, causing infection, pain, or stimulation failure. The pulse generator may malfunction, leak, or deplete, requiring replacement or reprogramming. These complications may require additional surgeries, which increase the risk of infection, bleeding, or damage to the brain or other organs. To reduce these risks, some researchers have suggested to use wireless or biodegradable DBS devices, which can eliminate the need for extension wires or pulse generators, or to use nanomaterials or coatings that can enhance the biocompatibility and longevity of the devices.

- A third technical issue of DBS is the potential side effects and complications of the surgery. The implantation of the DBS system requires a neurosurgical procedure that involves drilling holes in the skull, inserting electrodes into the brain, and placing the pulse generator under the skin. This procedure carries some inherent risks, such as infection, bleeding, stroke, seizure, or damage to the brain or other structures. These risks may vary depending on the patient's age, health, and anatomy, the target brain region, and the skill and experience of the surgeon. The incidence of these complications is estimated to be around 2-5% for the electrode implantation and 3-9% for the pulse generator implantation. Most of these complications are minor and transient, but some may be serious and permanent, such as paralysis, cognitive impairment, or death. Additionally, the stimulation of the brain may also cause some side effects, such as headache, nausea, dizziness, tingling, or muscle contractions. These side effects are usually mild and reversible, but some may be severe and persistent, such as speech impairment, vision problems, mood changes, or personality alterations. These side effects may depend on the stimulation parameters, the target brain region, and the individual sensitivity of the patient. The frequency and severity of these side effects may be reduced by adjusting the stimulation settings, switching off the device, or removing the electrodes.

- ethical and social issues: One of the main ethical and social issues of DBS is the impact of the stimulation on the patients' personality, autonomy, and identity. DBS may alter the patients' thoughts, feelings, preferences, values, or behaviors, which may affect their sense of self and their relationship with others. For example, DBS for Parkinson's disease may improve the patients' motor symptoms, but it may also induce impulsivity, apathy, or mania, which may impair their judgment, motivation, or mood. DBS for depression may alleviate the patients' mood, but it may also change their emotional expression, empathy, or creativity, which may influence their social interactions, hobbies, or careers. DBS for obsessive-compulsive disorder may reduce the patients' compulsions, but it may also modify their beliefs, interests, or morals, which may conflict with their previous values, goals, or identities. These changes may raise some questions, such as: Who is the real me? Am I still the same person? Do I have control over my actions? Do I have free will? Do I like who I have become? These questions may challenge the patients' self-concept, self-esteem, or self-determination, and may cause psychological distress, confusion, or alienation. To address these issues, some researchers have proposed to use patient-centered or value-based approaches, which can involve the patients in the decision-making process, respect their preferences and values, and support their autonomy and identity.

- Another ethical and social issue of DBS is the informed consent and decision-making process. DBS is a complex and invasive intervention that requires the patients to make a difficult and irreversible choice, which may have significant consequences for their health, well-being, and quality of life. However, the patients may not have the sufficient information, understanding, or capacity to make an informed and voluntary decision, especially if they suffer from cognitive impairment, mental illness, or emotional distress. Moreover, the patients may be influenced by external factors, such as the expectations, opinions, or pressures of their family, friends, or doctors, or by internal factors, such as the hope, desperation, or denial of their condition. These factors may affect the patients' judgment, motivation, or consent, and may compromise their autonomy, dignity, or welfare. To address these issues, some researchers have suggested to use multidisciplinary or participatory models, which can involve the patients, their caregivers, and their clinicians in a collaborative and transparent dialogue, provide them with accurate and comprehensive information, assess their competence and voluntariness, and respect their rights and interests.

- A third ethical and social issue of DBS is the social stigma and discrimination that may arise from using a brain implant. DBS may expose the patients to negative attitudes, stereotypes, or prejudices from the society, which may affect their self-image, self-confidence, or self-respect. For example, the patients may be perceived as abnormal, unnatural, or artificial, which may undermine their authenticity, integrity, or humanity. The patients may be viewed as dependent, vulnerable, or inferior, which may diminish their independence, dignity, or equality. The patients may be regarded as dangerous, unpredictable, or irresponsible, which may threaten their safety, trust, or accountability. These perceptions may lead to social exclusion, isolation, or rejection, which may impair the patients' social integration, participation, or inclusion. To address these issues, some researchers have recommended to use educational or advocacy strategies, which can inform the public about the benefits and risks of DBS, challenge the myths and misconceptions about DBS, and promote the acceptance and respect of DBS users.

6. New targets, paradigms, and technologies

Deep brain stimulation (DBS) is a rapidly evolving field that offers hope for patients with various neurological and psychiatric disorders. DBS involves the implantation of electrodes in specific brain regions and the delivery of electrical pulses to modulate neural activity. DBS has been shown to be effective in treating conditions such as Parkinson's disease, essential tremor, dystonia, epilepsy, obsessive-compulsive disorder, and depression. However, DBS also faces many challenges and limitations, such as the invasiveness of the procedure, the variability of the outcomes, the side effects of the stimulation, and the lack of mechanistic understanding of how DBS works. Therefore, there is a need for further research and innovation to improve the safety, efficacy, and applicability of DBS. Some of the promising directions and innovations of DBS are:

- New targets: DBS has traditionally targeted subcortical structures such as the subthalamic nucleus, the globus pallidus, and the thalamus. However, recent studies have explored the potential of stimulating other brain regions, such as the cortex, the cerebellum, the hippocampus, and the amygdala. These new targets may offer novel therapeutic options for disorders that are not responsive to conventional DBS, such as Alzheimer's disease, stroke, traumatic brain injury, and post-traumatic stress disorder. For example, a pilot study by Suthana et al. (2018) showed that DBS of the entorhinal cortex and the hippocampus improved memory performance in patients with mild cognitive impairment.

- New paradigms: DBS has typically used constant, high-frequency stimulation to achieve its effects. However, recent studies have suggested that alternative paradigms, such as intermittent, low-frequency, adaptive, or closed-loop stimulation, may be more effective, efficient, and personalized. These paradigms aim to optimize the stimulation parameters based on the patient's symptoms, neural activity, or behavioral feedback. For example, a study by Little et al. (2013) showed that adaptive DBS of the subthalamic nucleus, which adjusted the stimulation intensity according to the beta-band power of the local field potentials, reduced the power consumption and improved the motor symptoms in patients with Parkinson's disease compared to conventional DBS.

- New technologies: DBS has relied on the use of rigid, metal electrodes that are connected to an external pulse generator via a subcutaneous wire. However, recent advances in materials science, nanotechnology, wireless communication, and bioengineering have enabled the development of new technologies that may overcome some of the limitations of conventional DBS. These technologies include flexible, biocompatible, and biodegradable electrodes that can conform to the brain tissue and reduce the risk of infection and inflammation; wireless and implantable pulse generators that can eliminate the need for surgery and battery replacement; and optogenetic and chemogenetic approaches that can selectively stimulate or inhibit specific cell types or neurotransmitters. For example, a study by Chen et al. (2015) demonstrated the feasibility of using a wireless and implantable device to deliver optogenetic stimulation to the ventral tegmental area in mice, which induced reward-related behaviors.

7. Summary and implications of DBS for brain health and quality of life

Deep brain stimulation (DBS) is a promising technique that can modulate the activity of specific brain regions by delivering electrical impulses through implanted electrodes. DBS has been shown to be effective in treating various neurological and psychiatric disorders, such as Parkinson's disease, essential tremor, dystonia, epilepsy, obsessive-compulsive disorder, and depression. However, DBS is not without limitations and risks, and its mechanisms of action are still not fully understood. In this section, we will summarize the main findings and implications of DBS for brain health and quality of life, and discuss some of the future directions and challenges in this field.

Some of the key points that we have covered in this article are:

- DBS can improve the motor symptoms and quality of life of patients with Parkinson's disease, especially those who have developed complications from long-term medication use. DBS can also reduce the tremor and rigidity of patients with essential tremor and dystonia, respectively. However, DBS does not cure these diseases, and its effects may vary depending on the individual characteristics and the stimulation parameters.

- DBS can also modulate the mood and cognition of patients with psychiatric disorders, such as obsessive-compulsive disorder and depression. DBS can target different brain regions that are involved in the regulation of emotions, such as the subthalamic nucleus, the nucleus accumbens, the ventral capsule/ventral striatum, and the medial forebrain bundle. DBS can alter the neural activity and connectivity of these regions, and thus influence the behavioral and psychological outcomes of the patients. However, DBS is not a first-line treatment for these disorders, and its efficacy and safety are still under investigation.

- DBS can also have potential applications in enhancing the cognitive functions and memory of healthy individuals or patients with cognitive impairment, such as Alzheimer's disease. DBS can stimulate the hippocampus, the prefrontal cortex, or the fornix, which are important for learning and memory formation. DBS can increase the neurogenesis, synaptic plasticity, and blood flow in these regions, and thus improve the cognitive performance and recall of the subjects. However, DBS is not a magic bullet for cognitive enhancement, and its ethical and social implications are still controversial.

- DBS is a complex and invasive procedure that requires careful selection of candidates, surgical implantation of electrodes, and optimization of stimulation parameters. DBS can also cause adverse effects, such as infection, hemorrhage, hardware malfunction, and stimulation-induced side effects, such as speech impairment, mood changes, and cognitive decline. Therefore, DBS should be performed by experienced and multidisciplinary teams, and monitored by regular follow-ups and assessments.

- DBS is still a developing technique that faces many challenges and opportunities in the future. Some of the current limitations of DBS are the lack of specificity, adaptability, and feedback of the stimulation. Future DBS systems may incorporate novel technologies, such as nanoelectrodes, optogenetics, ultrasound, and closed-loop systems, to overcome these limitations and achieve more precise, personalized, and responsive stimulation. Moreover, future DBS research may explore new indications, targets, and mechanisms of DBS, and integrate DBS with other modalities, such as pharmacology, gene therapy, and neuroimaging, to enhance the understanding and outcomes of DBS.

DBS is a powerful and versatile technique that can modulate the brain activity and function of various disorders and domains. DBS can have significant impacts on the brain health and quality of life of the patients and the society. However, DBS is also a challenging and risky technique that requires careful consideration and evaluation of its benefits and harms. Therefore, DBS should be used with caution and respect, and with the aim of improving the well-being and dignity of the human beings.

8. Sources and further reading on DBS and brain stimulation devices

The field of brain stimulation devices is rapidly evolving, with new applications and mechanisms being discovered and explored. DBS is one of the most widely used and studied forms of brain stimulation, but it is not the only one. There are other devices that can modulate brain activity in different ways, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), and optogenetics. These devices have different advantages and disadvantages, depending on the target, the goal, the safety, and the cost of the intervention. In this section, we will provide some sources and further reading on DBS and other brain stimulation devices, covering various aspects such as:

- The history and development of DBS and other brain stimulation devices, from the early experiments to the current state of the art. For example, you can read about the origins of DBS in the book The Case of the Frozen Addicts by J. William Langston and Jon Palfreman, or the history of TMS in the article The Discovery of Transcranial Magnetic Stimulation by Alvaro Pascual-Leone and Mark Hallett.

- The basic principles and mechanisms of DBS and other brain stimulation devices, such as how they work, what they do, and what they don't do. For example, you can learn about the physics and physiology of DBS in the book Deep Brain Stimulation: A New Frontier in Psychiatry by Damiaan Denys and Martijn Figee, or the mechanisms and effects of tDCS in the article Transcranial Direct Current Stimulation: State of the Art 2008 by Michael A. Nitsche and Walter Paulus.

- The clinical applications and outcomes of DBS and other brain stimulation devices, such as what conditions they can treat, how effective they are, and what side effects they may have. For example, you can read about the use of DBS for Parkinson's disease in the article Deep Brain Stimulation for Parkinson's Disease by Andres M. Lozano and Elena Moro, or the use of TMS for depression in the article Transcranial Magnetic Stimulation for Depression by Mark S. George and Sarah H. Lisanby.

- The ethical and social implications of DBS and other brain stimulation devices, such as what are the risks, benefits, and challenges of using them, and how they may affect the identity, autonomy, and responsibility of the patients and the society. For example, you can explore the ethical issues of DBS in the book Deep Brain Stimulation and the Future of Neuroethics by Laura Y. Cabrera and Judy Illes, or the social implications of TMS in the article Transcranial Magnetic Stimulation and the Human Brain: An Ethical Evaluation by Eric Racine and Judy Illes.

Read Other Blogs